Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SUV39H2 | Q9H5I1 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.34 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.34 |
| ▸ | C5 | P01031 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6675894 | 0.83 | ALDH1A1 (0.42) | ALDH1A1GAAHTTLMNASMN1; SMN2 | |
| SCHEMBL6678686 | 0.82 | ALDH1A1 (0.43) | ALDH1A1GAAHTTLMNAKDM4E | |
| SCHEMBL6681088 | 0.79 | ALDH1A1 (0.44) | ALDH1A1GAAHTTLMNAIMPDH2 | |
| SCHEMBL6689914 | 0.78 | ALDH1A1 (0.41) | ALDH1A1GAAHTTSMN1; SMN2MEN1 | |
| SCHEMBL6679990 | 0.78 | ALDH1A1 (0.55) | ALDH1A1GAALMNASMN1; SMN2KDM4E | |
| SCHEMBL6674831 | 0.77 | PTPN1 (0.39) | ALDH1A1GAAKMT2A | |
| SCHEMBL6681938 | 0.77 | HTT (0.39) | ALDH1A1GAAHTTLMNASMN1; SMN2 | |
| SCHEMBL6675899 | 0.74 | KDM4E (0.37) | ALDH1A1GAAKDM4EMEN1KMT2A | |
| SCHEMBL6680547 | 0.73 | RXFP1 (0.41) | GAASMN1; SMN2MEN1KMT2A | |
| SCHEMBL6676957 | 0.73 | EGFR (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0798292-B1 | ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY | CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-6534546-B1 | Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-03-18 | — | — | US | disclosed |
| EP-0798292-A1 | ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY | Chugai Seiyaku Kabushiki Kaisha (JP) | 1997-10-01 | — | — | EP | disclosed |